Skip to main content
NCBI home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1995 Apr;8(2):180–199. doi: 10.1128/cmr.8.2.180

Tuberculosis in the AIDS era.

K A Sepkowitz 1, J Raffalli 1, L Riley 1, T E Kiehn 1, D Armstrong 1
PMCID: PMC172855  PMID: 7621399

Abstract

A resurgence of tuberculosis has occurred in recent years in the United States and abroad. Deteriorating public health services, increasing numbers of immigrants from countries of endemicity, and coinfection with the human immunodeficiency virus (HIV) have contributed to the rise in the number of cases diagnosed in the United States. Outbreaks of resistant tuberculosis, which responds poorly to therapy, have occurred in hospitals and other settings, affecting patients and health care workers. This review covers the pathogenesis, epidemiology, clinical presentation, laboratory diagnosis, and treatment of Mycobacterium tuberculosis infection and disease. In addition, public health and hospital infection control strategies are detailed. Newer approaches to epidemiologic investigation, including use of restriction fragment length polymorphism analysis, are discussed. Detailed consideration of the interaction between HIV infection and tuberculosis is given. We also review the latest techniques in laboratory evaluation, including the radiometric culture system, DNA probes, and PCR. Current recommendations for therapy of tuberculosis, including multidrug-resistant tuberculosis, are given. Finally, the special problem of prophylaxis of persons exposed to multidrug-resistant tuberculosis is considered.

Full Text

The Full Text of this article is available as a PDF (328.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALPERT M. E., LEVISON M. E. AN EPIDEMIC OF TUBERCULOSIS IN A MEDICAL SCHOOL. N Engl J Med. 1965 Apr 8;272:718–721. doi: 10.1056/NEJM196504082721404. [DOI] [PubMed] [Google Scholar]
  2. Abe C., Hosojima S., Fukasawa Y., Kazumi Y., Takahashi M., Hirano K., Mori T. Comparison of MB-Check, BACTEC, and egg-based media for recovery of mycobacteria. J Clin Microbiol. 1992 Apr;30(4):878–881. doi: 10.1128/jcm.30.4.878-881.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Acocella G., Angel J. H. Short-course chemotherapy of pulmonary tuberculosis: a new approach to drug dosage in the initial intensive phase. Am Rev Respir Dis. 1986 Dec;134(6):1283–1286. doi: 10.1164/arrd.1986.134.5.1283. [DOI] [PubMed] [Google Scholar]
  4. Addington W. W. Patient compliance: the most serious remaining problem in the control of tuberculosis in the United States. Chest. 1979 Dec;76(6 Suppl):741–743. doi: 10.1378/chest.76.6_supplement.741. [DOI] [PubMed] [Google Scholar]
  5. Adler J. J., di Ferdinando G., Jr Tuberculosis transmission among health care workers. N Y State J Med. 1991 Mar;91(3):89–90. [PubMed] [Google Scholar]
  6. Aitken M. L., Sparks R., Anderson K., Albert R. K. Predictors of drug-resistant Mycobacterium tuberculosis. Am Rev Respir Dis. 1984 Nov;130(5):831–833. doi: 10.1164/arrd.1984.130.5.831. [DOI] [PubMed] [Google Scholar]
  7. Allen S., Batungwanayo J., Kerlikowske K., Lifson A. R., Wolf W., Granich R., Taelman H., Van de Perre P., Serufilira A., Bogaerts J. Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. Am Rev Respir Dis. 1992 Dec;146(6):1439–1444. doi: 10.1164/ajrccm/146.6.1439. [DOI] [PubMed] [Google Scholar]
  8. Alvarez S., Kasprzyk D. R., Freundl M. Two-stage skin testing for tuberculosis in a domiciliary population. Am Rev Respir Dis. 1987 Nov;136(5):1193–1196. doi: 10.1164/ajrccm/136.5.1193. [DOI] [PubMed] [Google Scholar]
  9. Annas G. J. Control of tuberculosis--the law and the public's health. N Engl J Med. 1993 Feb 25;328(8):585–588. doi: 10.1056/NEJM199302253280825. [DOI] [PubMed] [Google Scholar]
  10. Aziz A., Ishaq M., Jaffer N. A., Akhwand R., Bhatti A. H. Clinical trial of two short-course (6-month) regimens and a standard regimen (12-month) chemotherapy in retreatment of pulmonary tuberculosis in Pakistan. Results 18 months after completion of treatment (Lahore Tuberculosis Study). Am Rev Respir Dis. 1986 Nov;134(5):1056–1061. doi: 10.1164/arrd.1986.134.5.1056. [DOI] [PubMed] [Google Scholar]
  11. BATES J. H., POTTS W. E., LEWIS M. EPIDEMIOLOGY OF PRIMARY TUBERCULOSIS IN AN INDUSTRIAL SCHOOL. N Engl J Med. 1965 Apr 8;272:714–717. doi: 10.1056/NEJM196504082721403. [DOI] [PubMed] [Google Scholar]
  12. Barclay W. R. BCG: an effective immunizing agent. JAMA. 1983 May 6;249(17):2376–2376. [PubMed] [Google Scholar]
  13. Barnes P. F., Barrows S. A. Tuberculosis in the 1990s. Ann Intern Med. 1993 Sep 1;119(5):400–410. doi: 10.7326/0003-4819-119-5-199309010-00009. [DOI] [PubMed] [Google Scholar]
  14. Barnes P. F., Bloch A. B., Davidson P. T., Snider D. E., Jr Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991 Jun 6;324(23):1644–1650. doi: 10.1056/NEJM199106063242307. [DOI] [PubMed] [Google Scholar]
  15. Barnes P. F. The influence of epidemiologic factors on drug resistance rates in tuberculosis. Am Rev Respir Dis. 1987 Aug;136(2):325–328. doi: 10.1164/ajrccm/136.2.325. [DOI] [PubMed] [Google Scholar]
  16. Bates J. H., Stead W. W. The history of tuberculosis as a global epidemic. Med Clin North Am. 1993 Nov;77(6):1205–1217. doi: 10.1016/s0025-7125(16)30188-2. [DOI] [PubMed] [Google Scholar]
  17. Baughman R. P., Dohn M. N., Loudon R. G., Frame P. T. Bronchoscopy with bronchoalveolar lavage in tuberculosis and fungal infections. Chest. 1991 Jan;99(1):92–97. doi: 10.1378/chest.99.1.92. [DOI] [PubMed] [Google Scholar]
  18. Baxter T. Low infectivity of tuberculosis. Lancet. 1993 Aug 7;342(8867):371–371. doi: 10.1016/0140-6736(93)91516-o. [DOI] [PubMed] [Google Scholar]
  19. Beck-Sagué C., Dooley S. W., Hutton M. D., Otten J., Breeden A., Crawford J. T., Pitchenik A. E., Woodley C., Cauthen G., Jarvis W. R. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. JAMA. 1992 Sep 9;268(10):1280–1286. doi: 10.1001/jama.1992.03490100078031. [DOI] [PubMed] [Google Scholar]
  20. Bellin E. Y., Fletcher D. D., Safyer S. M. Association of tuberculosis infection with increased time in or admission to the New York City jail system. JAMA. 1993 May 5;269(17):2228–2231. [PubMed] [Google Scholar]
  21. Ben-Dov I., Mason G. R. Drug-resistant tuberculosis in a southern California hospital. Trends from 1969 to 1984. Am Rev Respir Dis. 1987 Jun;135(6):1307–1310. doi: 10.1164/arrd.1987.135.6.1307. [DOI] [PubMed] [Google Scholar]
  22. Berenguer J., Moreno S., Laguna F., Vicente T., Adrados M., Ortega A., González-LaHoz J., Bouza E. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med. 1992 Mar 5;326(10):668–672. doi: 10.1056/NEJM199203053261004. [DOI] [PubMed] [Google Scholar]
  23. Berning S. E., Huitt G. A., Iseman M. D., Peloquin C. A. Malabsorption of antituberculosis medications by a patient with AIDS. N Engl J Med. 1992 Dec 17;327(25):1817–1818. doi: 10.1056/NEJM199212173272514. [DOI] [PubMed] [Google Scholar]
  24. Bishburg E., Sunderam G., Reichman L. B., Kapila R. Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex. Ann Intern Med. 1986 Aug;105(2):210–213. doi: 10.7326/0003-4819-105-2-210. [DOI] [PubMed] [Google Scholar]
  25. Bloom B. R., Murray C. J. Tuberculosis: commentary on a reemergent killer. Science. 1992 Aug 21;257(5073):1055–1064. doi: 10.1126/science.257.5073.1055. [DOI] [PubMed] [Google Scholar]
  26. Braun M. M., Badi N., Ryder R. W., Baende E., Mukadi Y., Nsuami M., Matela B., Willame J. C., Kaboto M., Heyward W. A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire. Am Rev Respir Dis. 1991 Mar;143(3):501–504. doi: 10.1164/ajrccm/143.3.501. [DOI] [PubMed] [Google Scholar]
  27. Braun M. M., Coté T. R., Rabkin C. S. Trends in death with tuberculosis during the AIDS era. JAMA. 1993 Jun 9;269(22):2865–2868. [PubMed] [Google Scholar]
  28. Braun M. M., Truman B. I., Maguire B., DiFerdinando G. T., Jr, Wormser G., Broaddus R., Morse D. L. Increasing incidence of tuberculosis in a prison inmate population. Association with HIV infection. JAMA. 1989 Jan 20;261(3):393–397. [PubMed] [Google Scholar]
  29. Brisson-Noel A., Aznar C., Chureau C., Nguyen S., Pierre C., Bartoli M., Bonete R., Pialoux G., Gicquel B., Garrigue G. Diagnosis of tuberculosis by DNA amplification in clinical practice evaluation. Lancet. 1991 Aug 10;338(8763):364–366. doi: 10.1016/0140-6736(91)90492-8. [DOI] [PubMed] [Google Scholar]
  30. Brisson-Noël A., Gicquel B., Lecossier D., Lévy-Frébault V., Nassif X., Hance A. J. Rapid diagnosis of tuberculosis by amplification of mycobacterial DNA in clinical samples. Lancet. 1989 Nov 4;2(8671):1069–1071. doi: 10.1016/s0140-6736(89)91082-9. [DOI] [PubMed] [Google Scholar]
  31. Brudney K., Dobkin J. A tale of two cities: tuberculosis control in Nicaragua and New York City. Semin Respir Infect. 1991 Dec;6(4):261–272. [PubMed] [Google Scholar]
  32. Brudney K., Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991 Oct;144(4):745–749. doi: 10.1164/ajrccm/144.4.745. [DOI] [PubMed] [Google Scholar]
  33. Busillo C. P., Lessnau K. D., Sanjana V., Soumakis S., Davidson M., Mullen M. P., Talavera W. Multidrug resistant Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. Chest. 1992 Sep;102(3):797–801. doi: 10.1378/chest.102.3.797. [DOI] [PubMed] [Google Scholar]
  34. Butler W. R., Kilburn J. O. Identification of major slowly growing pathogenic mycobacteria and Mycobacterium gordonae by high-performance liquid chromatography of their mycolic acids. J Clin Microbiol. 1988 Jan;26(1):50–53. doi: 10.1128/jcm.26.1.50-53.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Byrd R. B., Fisk D. E., Roethe R. A., Glover J. N., Wooster L. D., Wilder N. J. Tuberculosis in Oriental immigrants: a study in military dependents. Chest. 1979 Aug;76(2):136–139. doi: 10.1378/chest.76.2.136. [DOI] [PubMed] [Google Scholar]
  36. COMSTOCK G. W. Isoniazid prophylaxis in an undeveloped area. Am Rev Respir Dis. 1962 Dec;86:810–822. doi: 10.1164/arrd.1962.86.6.810. [DOI] [PubMed] [Google Scholar]
  37. Castelo A., Jardim J. R., Goihman S., Kalckman A. S., Dalboni M. A., da Silva E. A., Haynes R. B. Comparison of daily and twice-weekly regimens to treat pulmonary tuberculosis. Lancet. 1989 Nov 18;2(8673):1173–1176. doi: 10.1016/s0140-6736(89)91788-1. [DOI] [PubMed] [Google Scholar]
  38. Catanzaro A. Nosocomial tuberculosis. Am Rev Respir Dis. 1982 May;125(5):559–562. doi: 10.1164/arrd.1982.125.5.559. [DOI] [PubMed] [Google Scholar]
  39. Chaisson R. E., Schecter G. F., Theuer C. P., Rutherford G. W., Echenberg D. F., Hopewell P. C. Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis. 1987 Sep;136(3):570–574. doi: 10.1164/ajrccm/136.3.570. [DOI] [PubMed] [Google Scholar]
  40. Chaisson R. E., Slutkin G. Tuberculosis and human immunodeficiency virus infection. J Infect Dis. 1989 Jan;159(1):96–100. doi: 10.1093/infdis/159.1.96. [DOI] [PubMed] [Google Scholar]
  41. Charney W., Fisher J., Ishida C. The inefficiency of surgical masks for protection against droplet nuclei tuberculosis. J Occup Med. 1991 Sep;33(9):943–944. [PubMed] [Google Scholar]
  42. Chawla P. K., Klapper P. J., Kamholz S. L., Pollack A. H., Heurich A. E. Drug-resistant tuberculosis in an urban population including patients at risk for human immunodeficiency virus infection. Am Rev Respir Dis. 1992 Aug;146(2):280–284. doi: 10.1164/ajrccm/146.2.280. [DOI] [PubMed] [Google Scholar]
  43. Cheung R., Dickins J., Nicholson P. W., Thomas A. S., Smith H. H., Larson H. E., Deshmukh A. A., Dobbs R. J., Dobbs S. M. Compliance with anti-tuberculous therapy: a field trial of a pill-box with a concealed electronic recording device. Eur J Clin Pharmacol. 1988;35(4):401–407. doi: 10.1007/BF00561372. [DOI] [PubMed] [Google Scholar]
  44. Clemens J. D., Chuong J. J., Feinstein A. R. The BCG controversy. A methodological and statistical reappraisal. JAMA. 1983 May 6;249(17):2362–2369. [PubMed] [Google Scholar]
  45. Cohn D. L., Catlin B. J., Peterson K. L., Judson F. N., Sbarbaro J. A. A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen. Ann Intern Med. 1990 Mar 15;112(6):407–415. doi: 10.7326/0003-4819-76-3-112-6-407. [DOI] [PubMed] [Google Scholar]
  46. Colditz G. A., Brewer T. F., Berkey C. S., Wilson M. E., Burdick E., Fineberg H. V., Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. 1994 Mar 2;271(9):698–702. [PubMed] [Google Scholar]
  47. Combs D. L., O'Brien R. J., Geiter L. J. USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results. Ann Intern Med. 1990 Mar 15;112(6):397–406. doi: 10.7326/0003-4819-76-3-112-6-397. [DOI] [PubMed] [Google Scholar]
  48. Comstock G. W., Baum C., Snider D. E., Jr Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis. 1979 May;119(5):827–830. doi: 10.1164/arrd.1979.119.5.827. [DOI] [PubMed] [Google Scholar]
  49. Comstock G. W., Ferebee S. H., Hammes L. M. A controlled trial of community-wide isoniazid prophylaxis in Alaska. Am Rev Respir Dis. 1967 Jun;95(6):935–943. doi: 10.1164/arrd.1967.95.6.935. [DOI] [PubMed] [Google Scholar]
  50. Comstock G. W., Livesay V. T., Woolpert S. F. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol. 1974 Feb;99(2):131–138. doi: 10.1093/oxfordjournals.aje.a121593. [DOI] [PubMed] [Google Scholar]
  51. Coronado V. G., Beck-Sague C. M., Hutton M. D., Davis B. J., Nicholas P., Villareal C., Woodley C. L., Kilburn J. O., Crawford J. T., Frieden T. R. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis. 1993 Oct;168(4):1052–1055. doi: 10.1093/infdis/168.4.1052. [DOI] [PubMed] [Google Scholar]
  52. Cousins D. V., Wilton S. D., Francis B. R., Gow B. L. Use of polymerase chain reaction for rapid diagnosis of tuberculosis. J Clin Microbiol. 1992 Jan;30(1):255–258. doi: 10.1128/jcm.30.1.255-258.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Crowle A. J., Sbarbaro J. A., Judson F. N., May M. H. The effect of ethambutol on tubercle bacilli within cultured human macrophages. Am Rev Respir Dis. 1985 Oct;132(4):742–745. doi: 10.1164/arrd.1985.132.4.742. [DOI] [PubMed] [Google Scholar]
  54. Daley C. L., Small P. M., Schecter G. F., Schoolnik G. K., McAdam R. A., Jacobs W. R., Jr, Hopewell P. C. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992 Jan 23;326(4):231–235. doi: 10.1056/NEJM199201233260404. [DOI] [PubMed] [Google Scholar]
  55. Daley C. L. Tuberculosis recurrence in Africa: true relapse or re-infection? Lancet. 1993 Sep 25;342(8874):756–757. doi: 10.1016/0140-6736(93)91535-t. [DOI] [PubMed] [Google Scholar]
  56. Darney P. D., Clenny N. D. Tuberculosis outbreak in an Alabama High School. JAMA. 1971 Jun 28;216(13):2117–2118. [PubMed] [Google Scholar]
  57. Datta M., Radhamani M. P., Selvaraj R., Paramasivan C. N., Gopalan B. N., Sudeendra C. R., Prabhakar R. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme. Tuber Lung Dis. 1993 Jun;74(3):180–186. doi: 10.1016/0962-8479(93)90008-L. [DOI] [PubMed] [Google Scholar]
  58. De Cock K. M., Soro B., Coulibaly I. M., Lucas S. B. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA. 1992 Sep 23;268(12):1581–1587. doi: 10.1001/jama.268.12.1581. [DOI] [PubMed] [Google Scholar]
  59. Di Perri G., Cruciani M., Danzi M. C., Luzzati R., De Checchi G., Malena M., Pizzighella S., Mazzi R., Solbiati M., Concia E. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet. 1989 Dec 23;2(8678-8679):1502–1504. [PubMed] [Google Scholar]
  60. Dooley S. W., Jarvis W. R., Martone W. J., Snider D. E., Jr Multidrug-resistant tuberculosis. Ann Intern Med. 1992 Aug 1;117(3):257–259. doi: 10.7326/0003-4819-117-3-257. [DOI] [PubMed] [Google Scholar]
  61. Dooley S. W., Jr, Castro K. G., Hutton M. D., Mullan R. J., Polder J. A., Snider D. E., Jr Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR Recomm Rep. 1990 Dec 7;39(RR-17):1–29. [PubMed] [Google Scholar]
  62. Dooley S. W., Villarino M. E., Lawrence M., Salinas L., Amil S., Rullan J. V., Jarvis W. R., Bloch A. B., Cauthen G. M. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA. 1992 May 20;267(19):2632–2634. [PubMed] [Google Scholar]
  63. Doster B., Caras G. J., Snider D. E. A continuing survey of primary drug resistance in tuberculosis, 1961 to 1968. A U.S. Public Health Service cooperative study. Am Rev Respir Dis. 1976 Apr;113(4):419–425. doi: 10.1164/arrd.1976.113.4.419. [DOI] [PubMed] [Google Scholar]
  64. Dutt A. K., Moers D., Stead W. W. Short-course chemotherapy for extrapulmonary tuberculosis. Nine years' experience. Ann Intern Med. 1986 Jan;104(1):7–12. doi: 10.7326/0003-4819-104-1-7. [DOI] [PubMed] [Google Scholar]
  65. Dutt A. K., Moers D., Stead W. W. Smear- and culture-negative pulmonary tuberculosis: four-month short-course chemotherapy. Am Rev Respir Dis. 1989 Apr;139(4):867–870. doi: 10.1164/ajrccm/139.4.867. [DOI] [PubMed] [Google Scholar]
  66. Dutt A. K., Moers D., Stead W. W. Tuberculous pleural effusion: 6-month therapy with isoniazid and rifampin. Am Rev Respir Dis. 1992 Jun;145(6):1429–1432. doi: 10.1164/ajrccm/145.6.1429. [DOI] [PubMed] [Google Scholar]
  67. Dylewski J., Thibert L. Failure of tuberculosis chemotherapy in a human immunodeficiency virus-infected patient. J Infect Dis. 1990 Sep;162(3):778–779. doi: 10.1093/infdis/162.3.778. [DOI] [PubMed] [Google Scholar]
  68. EDWARDS P. Q., EDWADS L. B. Story of the tuberculin test from an epidemiologic viewpoint. Am Rev Respir Dis. 1960 Jan;81(1):1–47. [PubMed] [Google Scholar]
  69. Edlin B. R., Tokars J. I., Grieco M. H., Crawford J. T., Williams J., Sordillo E. M., Ong K. R., Kilburn J. O., Dooley S. W., Castro K. G. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992 Jun 4;326(23):1514–1521. doi: 10.1056/NEJM199206043262302. [DOI] [PubMed] [Google Scholar]
  70. Ehrenkranz N. J., Kicklighter J. L. Tuberculosis outbreak in a general hospital: evidence for airborne spread of infection. Ann Intern Med. 1972 Sep;77(3):377–382. doi: 10.7326/0003-4819-77-3-377. [DOI] [PubMed] [Google Scholar]
  71. Eisenach K. D., Cave M. D., Bates J. H., Crawford J. T. Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis. J Infect Dis. 1990 May;161(5):977–981. doi: 10.1093/infdis/161.5.977. [DOI] [PubMed] [Google Scholar]
  72. Ellner J. J., Hinman A. R., Dooley S. W., Fischl M. A., Sepkowitz K. A., Goldberger M. J., Shinnick T. M., Iseman M. D., Jacobs W. R., Jr Tuberculosis symposium: emerging problems and promise. J Infect Dis. 1993 Sep;168(3):537–551. doi: 10.1093/infdis/168.3.537. [DOI] [PubMed] [Google Scholar]
  73. Ellner P. D., Kiehn T. E., Cammarata R., Hosmer M. Rapid detection and identification of pathogenic mycobacteria by combining radiometric and nucleic acid probe methods. J Clin Microbiol. 1988 Jul;26(7):1349–1352. doi: 10.1128/jcm.26.7.1349-1352.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Evans K. D., Nakasone A. S., Sutherland P. A., de la Maza L. M., Peterson E. M. Identification of Mycobacterium tuberculosis and Mycobacterium avium-M. intracellulare directly from primary BACTEC cultures by using acridinium-ester-labeled DNA probes. J Clin Microbiol. 1992 Sep;30(9):2427–2431. doi: 10.1128/jcm.30.9.2427-2431.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Fairshter R. D., Randazzo G. P., Garlin J., Wilson A. F. Failure of isoniazid prophylaxis after exposure to isoniazid-resistant tuberculosis. Am Rev Respir Dis. 1975 Jul;112(1):37–42. doi: 10.1164/arrd.1975.112.1.37. [DOI] [PubMed] [Google Scholar]
  76. Farga V., Valenzuela P., Mendoza F., Torres E., Icekson I., Grinspun M., Fernández M., Corradini A., Martínez M., Velasco J. Chimiotherapie de courte durée. Essais opérationnels contrôlés au Chili. Bull Int Union Tuberc. 1983 Jun;58(2):102–107. [PubMed] [Google Scholar]
  77. Ferebee S. H. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970;26:28–106. [PubMed] [Google Scholar]
  78. Fischl M. A., Daikos G. L., Uttamchandani R. B., Poblete R. B., Moreno J. N., Reyes R. R., Boota A. M., Thompson L. M., Cleary T. J., Oldham S. A. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med. 1992 Aug 1;117(3):184–190. doi: 10.7326/0003-4819-117-3-184. [DOI] [PubMed] [Google Scholar]
  79. Fischl M. A., Uttamchandani R. B., Daikos G. L., Poblete R. B., Moreno J. N., Reyes R. R., Boota A. M., Thompson L. M., Cleary T. J., Lai S. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med. 1992 Aug 1;117(3):177–183. doi: 10.7326/0003-4819-117-3-177. [DOI] [PubMed] [Google Scholar]
  80. FitzGerald J. M., Grzybowski S., Allen E. A. The impact of human immunodeficiency virus infection on tuberculosis and its control. Chest. 1991 Jul;100(1):191–200. doi: 10.1378/chest.100.1.191. [DOI] [PubMed] [Google Scholar]
  81. Frampton M. W. An outbreak of tuberculosis among hospital personnel caring for a patient with a skin ulcer. Ann Intern Med. 1992 Aug 15;117(4):312–313. doi: 10.7326/0003-4819-117-4-312. [DOI] [PubMed] [Google Scholar]
  82. Frieden T. R., Sterling T., Pablos-Mendez A., Kilburn J. O., Cauthen G. M., Dooley S. W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993 Feb 25;328(8):521–526. doi: 10.1056/NEJM199302253280801. [DOI] [PubMed] [Google Scholar]
  83. Friedman L. N., Sullivan G. M., Bevilaqua R. P., Loscos R. Tuberculosis screening in alcoholics and drug addicts. Am Rev Respir Dis. 1987 Nov;136(5):1188–1192. doi: 10.1164/ajrccm/136.5.1188. [DOI] [PubMed] [Google Scholar]
  84. GRIGG E. R. The arcana of tuberculosis with a brief epidemiologic history of the disease in the U.S.A. IV. Am Rev Tuberc. 1958 Oct;78(4):583–603. [PubMed] [Google Scholar]
  85. Gangadharam P. R. Short-course chemotherapy of pulmonary tuberculosis: a new approach to drug dosage in the initial intensive phase. Am Rev Respir Dis. 1987 Dec;136(6):1518–1518. doi: 10.1164/ajrccm/136.6.1518. [DOI] [PubMed] [Google Scholar]
  86. Geiter L. J., O'Brien R. J. Short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis. 1987 May;135(5):1215–1215. doi: 10.1164/arrd.1987.135.5.1215. [DOI] [PubMed] [Google Scholar]
  87. Genewein A., Telenti A., Bernasconi C., Mordasini C., Weiss S., Maurer A. M., Rieder H. L., Schopfer K., Bodmer T. Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet. 1993 Oct 2;342(8875):841–844. doi: 10.1016/0140-6736(93)92698-s. [DOI] [PubMed] [Google Scholar]
  88. George R. H., Gully P. R., Gill O. N., Innes J. A., Bakhshi S. S., Connolly M. An outbreak of tuberculosis in a children's hospital. J Hosp Infect. 1986 Sep;8(2):129–142. doi: 10.1016/0195-6701(86)90039-3. [DOI] [PubMed] [Google Scholar]
  89. Gibbs J. H., Grange J. M., Beck J. S., Jawad E., Potts R. C., Bothamley G. H., Kardjito T. Early delayed hypersensitivity responses in tuberculin skin tests after heavy occupational exposure to tuberculosis. J Clin Pathol. 1991 Nov;44(11):919–923. doi: 10.1136/jcp.44.11.919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Glaser J. B., Greifinger R. B. Correctional health care: a public health opportunity. Ann Intern Med. 1993 Jan 15;118(2):139–145. doi: 10.7326/0003-4819-118-2-199301150-00010. [DOI] [PubMed] [Google Scholar]
  91. Glassroth J. Tuberculosis in the United States. Looking for a silver lining among the clouds. Am Rev Respir Dis. 1992 Aug;146(2):278–279. doi: 10.1164/ajrccm/146.2.278. [DOI] [PubMed] [Google Scholar]
  92. Goble M., Iseman M. D., Madsen L. A., Waite D., Ackerson L., Horsburgh C. R., Jr Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993 Feb 25;328(8):527–532. doi: 10.1056/NEJM199302253280802. [DOI] [PubMed] [Google Scholar]
  93. Goldberger M. J. Antituberculosis agents. Med Clin North Am. 1988 May;72(3):661–668. doi: 10.1016/s0025-7125(16)30764-7. [DOI] [PubMed] [Google Scholar]
  94. Goldsmith M. F. Forgotten (almost) but not gone, tuberculosis suddenly looms large on domestic scene. JAMA. 1990 Jul 11;264(2):165–166. [PubMed] [Google Scholar]
  95. Good R. C., Mastro T. D. The modern mycobacteriology laboratory. How it can help the clinician. Clin Chest Med. 1989 Sep;10(3):315–322. [PubMed] [Google Scholar]
  96. Gordin F., Slutkin G. The validity of acid-fast smears in the diagnosis of pulmonary tuberculosis. Arch Pathol Lab Med. 1990 Oct;114(10):1025–1027. [PubMed] [Google Scholar]
  97. Gordin F. Tuberculosis control. Back to the future? JAMA. 1992 May 20;267(19):2649–2650. doi: 10.1001/jama.267.19.2649. [DOI] [PubMed] [Google Scholar]
  98. Gorzynski E. A., Gutman S. I., Allen W. Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin. Antimicrob Agents Chemother. 1989 Apr;33(4):591–592. doi: 10.1128/aac.33.4.591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Gostin L. O. Controlling the resurgent tuberculosis epidemic. A 50-state survey of TB statutes and proposals for reform. JAMA. 1993 Jan 13;269(2):255–261. doi: 10.1001/jama.269.2.255. [DOI] [PubMed] [Google Scholar]
  100. Goto M., Oka S., Okuzumi K., Kimura S., Shimada K. Evaluation of acridinium-ester-labeled DNA probes for identification of Mycobacterium tuberculosis and Mycobacterium avium-Mycobacterium intracellulare complex in culture. J Clin Microbiol. 1991 Nov;29(11):2473–2476. doi: 10.1128/jcm.29.11.2473-2476.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Graham N. M., Nelson K. E., Solomon L., Bonds M., Rizzo R. T., Scavotto J., Astemborski J., Vlahov D. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA. 1992 Jan 15;267(3):369–373. [PubMed] [Google Scholar]
  102. Greenberg P. D., Lax K. G., Schechter C. B. Tuberculosis in house staff. A decision analysis comparing the tuberculin screening strategy with the BCG vaccination. Am Rev Respir Dis. 1991 Mar;143(3):490–495. doi: 10.1164/ajrccm/143.3.490. [DOI] [PubMed] [Google Scholar]
  103. Grist N. R., Emslie J. A. Infections in British clinical laboratories, 1988-1989. J Clin Pathol. 1991 Aug;44(8):667–669. doi: 10.1136/jcp.44.8.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Grosset J. H. Present status of chemotherapy for tuberculosis. Rev Infect Dis. 1989 Mar-Apr;11 (Suppl 2):S347–S352. doi: 10.1093/clinids/11.supplement_2.s347. [DOI] [PubMed] [Google Scholar]
  105. Grosset J. Bacteriologic basis of short-course chemotherapy for tuberculosis. Clin Chest Med. 1980 May;1(2):231–241. [PubMed] [Google Scholar]
  106. Grzybowski S., Barnett G. D., Styblo K. Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc. 1975;50(1):90–106. [PubMed] [Google Scholar]
  107. Haas D. W., Des Prez R. M. Tuberculosis and acquired immunodeficiency syndrome: a historical perspective on recent developments. Am J Med. 1994 May;96(5):439–450. doi: 10.1016/0002-9343(94)90171-6. [DOI] [PubMed] [Google Scholar]
  108. Haas W. H., Butler W. R., Woodley C. L., Crawford J. T. Mixed-linker polymerase chain reaction: a new method for rapid fingerprinting of isolates of the Mycobacterium tuberculosis complex. J Clin Microbiol. 1993 May;31(5):1293–1298. doi: 10.1128/jcm.31.5.1293-1298.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Haley C. E., McDonald R. C., Rossi L., Jones W. D., Jr, Haley R. W., Luby J. P. Tuberculosis epidemic among hospital personnel. Infect Control Hosp Epidemiol. 1989 May;10(5):204–210. doi: 10.1086/646003. [DOI] [PubMed] [Google Scholar]
  110. Hance A. J., Grandchamp B., Lévy-Frébault V., Lecossier D., Rauzier J., Bocart D., Gicquel B. Detection and identification of mycobacteria by amplification of mycobacterial DNA. Mol Microbiol. 1989 Jul;3(7):843–849. doi: 10.1111/j.1365-2958.1989.tb00233.x. [DOI] [PubMed] [Google Scholar]
  111. Hardy M. A., Schmidek H. H. Epidemiology of tuberculosis aboard a ship. JAMA. 1968 Jan 15;203(3):175–179. [PubMed] [Google Scholar]
  112. Hartstein M., Leaf H. L. Tuberculosis of the breast as a presenting manifestation of AIDS. Clin Infect Dis. 1992 Oct;15(4):692–693. doi: 10.1093/clind/15.4.692. [DOI] [PubMed] [Google Scholar]
  113. Hawken M., Nunn P., Gathua S., Brindle R., Godfrey-Faussett P., Githui W., Odhiambo J., Batchelor B., Gilks C., Morris J. Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya. Lancet. 1993 Aug 7;342(8867):332–337. doi: 10.1016/0140-6736(93)91474-z. [DOI] [PubMed] [Google Scholar]
  114. Hermans P. W., Schuitema A. R., Van Soolingen D., Verstynen C. P., Bik E. M., Thole J. E., Kolk A. H., van Embden J. D. Specific detection of Mycobacterium tuberculosis complex strains by polymerase chain reaction. J Clin Microbiol. 1990 Jun;28(6):1204–1213. doi: 10.1128/jcm.28.6.1204-1213.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Hewlett D., Jr, Duncanson F. P., Jagadha V., Lieberman J., Lenox T. H., Wormser G. P. Lymphadenopathy in an inner-city population consisting principally of intravenous drug abusers with suspected acquired immunodeficiency syndrome. Am Rev Respir Dis. 1988 Jun;137(6):1275–1279. doi: 10.1164/ajrccm/137.6.1275. [DOI] [PubMed] [Google Scholar]
  116. Holmberg S. D. The rise of tuberculosis in America before 1820. Am Rev Respir Dis. 1990 Nov;142(5):1228–1232. doi: 10.1164/ajrccm/142.5.1228. [DOI] [PubMed] [Google Scholar]
  117. Horn D. L., Hewlett D., Jr, Alfalla C., Peterson S., Opal S. M. Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis. N Engl J Med. 1994 Apr 28;330(17):1241–1241. doi: 10.1056/nejm199404283301718. [DOI] [PubMed] [Google Scholar]
  118. Horn D. L., Hewlett D., Jr, Haas W. H., Butler W. R., Alfalla C., Tan E., Levine A., Nayak A., Opal S. M. Superinfection with rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant tuberculosis in three patients with AIDS: confirmation by polymerase chain reaction fingerprinting. Ann Intern Med. 1994 Jul 15;121(2):115–116. doi: 10.7326/0003-4819-121-2-199407150-00007. [DOI] [PubMed] [Google Scholar]
  119. Horsfall P. A. Treatment of resistant pulmonary tuberculosis in Hong Kong with regimens of second-line drugs. Tubercle. 1972 Sep;53(3):166–173. doi: 10.1016/0041-3879(72)90013-x. [DOI] [PubMed] [Google Scholar]
  120. Houk V. N., Baker J. H., Sorensen K., Kent D. C. The epidemiology of tuberculosis infection in a closed environment. Arch Environ Health. 1968 Jan;16(1):26–35. doi: 10.1080/00039896.1968.10665011. [DOI] [PubMed] [Google Scholar]
  121. Huebner R. E., Good R. C., Tokars J. I. Current practices in mycobacteriology: results of a survey of state public health laboratories. J Clin Microbiol. 1993 Apr;31(4):771–775. doi: 10.1128/jcm.31.4.771-775.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Hutton M. D., Stead W. W., Cauthen G. M., Bloch A. B., Ewing W. M. Nosocomial transmission of tuberculosis associated with a draining abscess. J Infect Dis. 1990 Feb;161(2):286–295. doi: 10.1093/infdis/161.2.286. [DOI] [PubMed] [Google Scholar]
  123. Iseman M. D. A leap of faith. What can we do to curtail intrainstitutional transmission of tuberculosis? Ann Intern Med. 1992 Aug 1;117(3):251–253. doi: 10.7326/0003-4819-117-3-251. [DOI] [PubMed] [Google Scholar]
  124. Iseman M. D., Cohn D. L., Sbarbaro J. A. Directly observed treatment of tuberculosis. We can't afford not to try it. N Engl J Med. 1993 Feb 25;328(8):576–578. doi: 10.1056/NEJM199302253280811. [DOI] [PubMed] [Google Scholar]
  125. Iseman M. D. Is standard chemotherapy adequate in tuberculosis patients infected with the HIV? Am Rev Respir Dis. 1987 Dec;136(6):1326–1326. doi: 10.1164/ajrccm/136.6.1325. [DOI] [PubMed] [Google Scholar]
  126. Iseman M. D., Madsen L., Goble M., Pomerantz M. Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis. Am Rev Respir Dis. 1990 Mar;141(3):623–625. doi: 10.1164/ajrccm/141.3.623. [DOI] [PubMed] [Google Scholar]
  127. Iseman M. D., Sbarbaro J. A. Short-course chemotherapy of tuberculosis. Hail Britannia (and friends)! Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):697–698. doi: 10.1164/ajrccm/143.4_Pt_1.697. [DOI] [PubMed] [Google Scholar]
  128. Iseman M. D. Treatment of multidrug-resistant tuberculosis. N Engl J Med. 1993 Sep 9;329(11):784–791. doi: 10.1056/NEJM199309093291108. [DOI] [PubMed] [Google Scholar]
  129. Isenberg H. D., D'Amato R. F., Heifets L., Murray P. R., Scardamaglia M., Jacobs M. C., Alperstein P., Niles A. Collaborative feasibility study of a biphasic system (Roche Septi-Chek AFB) for rapid detection and isolation of mycobacteria. J Clin Microbiol. 1991 Aug;29(8):1719–1722. doi: 10.1128/jcm.29.8.1719-1722.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Jacobs W. R., Jr, Barletta R. G., Udani R., Chan J., Kalkut G., Sosne G., Kieser T., Sarkis G. J., Hatfull G. F., Bloom B. R. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science. 1993 May 7;260(5109):819–822. doi: 10.1126/science.8484123. [DOI] [PubMed] [Google Scholar]
  131. Jereb J. A., Burwen D. R., Dooley S. W., Haas W. H., Crawford J. T., Geiter L. J., Edmond M. B., Dowling J. N., Shapiro R., Pasculle A. W. Nosocomial outbreak of tuberculosis in a renal transplant unit: application of a new technique for restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates. J Infect Dis. 1993 Nov;168(5):1219–1224. doi: 10.1093/infdis/168.5.1219. [DOI] [PubMed] [Google Scholar]
  132. Jereb J. A., Kelly G. D., Dooley S. W., Jr, Cauthen G. M., Snider D. E., Jr Tuberculosis morbidity in the United States: final data, 1990. MMWR CDC Surveill Summ. 1991 Dec;40(3):23–27. [PubMed] [Google Scholar]
  133. Jones B. E., Young S. M., Antoniskis D., Davidson P. T., Kramer F., Barnes P. F. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis. 1993 Nov;148(5):1292–1297. doi: 10.1164/ajrccm/148.5.1292. [DOI] [PubMed] [Google Scholar]
  134. Kantor H. S., Poblete R., Pusateri S. L. Nosocomial transmission of tuberculosis from unsuspected disease. Am J Med. 1988 May;84(5):833–838. doi: 10.1016/0002-9343(88)90060-5. [DOI] [PubMed] [Google Scholar]
  135. Kaplan M. H., Armstrong D., Rosen P. Tuberculosis complicating neoplastic disease. A review of 201 cases. Cancer. 1974 Mar;33(3):850–858. doi: 10.1002/1097-0142(197403)33:3<850::aid-cncr2820330334>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  136. Kennedy N., Fox R., Kisyombe G. M., Saruni A. O., Uiso L. O., Ramsay A. R., Ngowi F. I., Gillespie S. H. Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis. Am Rev Respir Dis. 1993 Dec;148(6 Pt 1):1547–1551. doi: 10.1164/ajrccm/148.6_Pt_1.1547. [DOI] [PubMed] [Google Scholar]
  137. Kiehn T. E., Cammarata R. Comparative recoveries of Mycobacterium avium-M. intracellulare from isolator lysis-centrifugation and BACTEC 13A blood culture systems. J Clin Microbiol. 1988 Apr;26(4):760–761. doi: 10.1128/jcm.26.4.760-761.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Kiehn T. E. The diagnostic mycobacteriology laboratory of the 1990s. Clin Infect Dis. 1993 Nov;17 (Suppl 2):S447–S454. doi: 10.1093/clinids/17.supplement_2.s447. [DOI] [PubMed] [Google Scholar]
  139. Kim S. J., Hong Y. P. Drug resistance of Mycobacterium tuberculosis in Korea. Tuber Lung Dis. 1992 Aug;73(4):219–224. doi: 10.1016/0962-8479(92)90090-7. [DOI] [PubMed] [Google Scholar]
  140. Kissner D. G. Tuberculosis. Missed opportunities. Arch Intern Med. 1987 Nov;147(11):2037–2040. doi: 10.1001/archinte.147.11.2037. [DOI] [PubMed] [Google Scholar]
  141. Klotz S. A., Penn R. L. Acid-fast staining of urine and gastric contents is an excellent indicator of mycobacterial disease. Am Rev Respir Dis. 1987 Nov;136(5):1197–1198. doi: 10.1164/ajrccm/136.5.1197. [DOI] [PubMed] [Google Scholar]
  142. Knockaert D. C., Vanneste L. J., Vanneste S. B., Bobbaers H. J. Fever of unknown origin in the 1980s. An update of the diagnostic spectrum. Arch Intern Med. 1992 Jan;152(1):51–55. [PubMed] [Google Scholar]
  143. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle. 1991 Mar;72(1):1–6. doi: 10.1016/0041-3879(91)90017-m. [DOI] [PubMed] [Google Scholar]
  144. Kohno S., Koga H., Kaku M., Maesaki S., Hara K. Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis. Chest. 1992 Dec;102(6):1815–1818. doi: 10.1378/chest.102.6.1815. [DOI] [PubMed] [Google Scholar]
  145. Kopanoff D. E., Kilburn J. O., Glassroth J. L., Snider D. E., Jr, Farer L. S., Good R. C. A continuing survey of tuberculosis primary drug resistance in the United States: March 1975 to November 1977. A United States Public Health Service cooperative study. Am Rev Respir Dis. 1978 Nov;118(5):835–842. doi: 10.1164/arrd.1978.118.5.835. [DOI] [PubMed] [Google Scholar]
  146. Kramer F., Modilevsky T., Waliany A. R., Leedom J. M., Barnes P. F. Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med. 1990 Oct;89(4):451–456. doi: 10.1016/0002-9343(90)90375-n. [DOI] [PubMed] [Google Scholar]
  147. Kramer F., Sasse S. A., Simms J. C., Leedom J. M. Primary cutaneous tuberculosis after a needlestick injury from a patient with AIDS and undiagnosed tuberculosis. Ann Intern Med. 1993 Oct 1;119(7 Pt 1):594–595. doi: 10.7326/0003-4819-119-7_part_1-199310010-00007. [DOI] [PubMed] [Google Scholar]
  148. Larson E. B., Featherstone H. J., Petersdorf R. G. Fever of undetermined origin: diagnosis and follow-up of 105 cases, 1970-1980. Medicine (Baltimore) 1982 Sep;61(5):269–292. [PubMed] [Google Scholar]
  149. Lecoeur H. F., Truffot-Pernot C., Grosset J. H. Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide. Am Rev Respir Dis. 1989 Nov;140(5):1189–1193. doi: 10.1164/ajrccm/140.5.1189. [DOI] [PubMed] [Google Scholar]
  150. Levy S. B. Confronting multidrug resistance. A role for each of us. JAMA. 1993 Apr 14;269(14):1840–1842. doi: 10.1001/jama.269.14.1840. [DOI] [PubMed] [Google Scholar]
  151. Lin T. P., Suo J., Lee C. N., Lee J. J., Yang S. P. Short-course chemotherapy of pulmonary tuberculosis in pneumoconiotic patients. Am Rev Respir Dis. 1987 Oct;136(4):808–810. doi: 10.1164/ajrccm/136.4.808. [DOI] [PubMed] [Google Scholar]
  152. Lincoln E. M. Epidemics of tuberculosis. Bibl Tuberc. 1965;21:157–201. [PubMed] [Google Scholar]
  153. Louie E., Rice L. B., Holzman R. S. Tuberculosis in non-Haitian patients with acquired immunodeficiency syndrome. Chest. 1986 Oct;90(4):542–545. doi: 10.1378/chest.90.4.542. [DOI] [PubMed] [Google Scholar]
  154. Lupatkin H., Bräu N., Flomenberg P., Simberkoff M. S. Tuberculous abscesses in patients with AIDS. Clin Infect Dis. 1992 May;14(5):1040–1044. doi: 10.1093/clinids/14.5.1040. [DOI] [PubMed] [Google Scholar]
  155. Mahmoudi A., Iseman M. D. Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance. JAMA. 1993 Jul 7;270(1):65–68. [PubMed] [Google Scholar]
  156. Malasky C., Jordan T., Potulski F., Reichman L. B. Occupational tuberculous infections among pulmonary physicians in training. Am Rev Respir Dis. 1990 Sep;142(3):505–507. doi: 10.1164/ajrccm/142.3.505. [DOI] [PubMed] [Google Scholar]
  157. Manalo F., Tan F., Sbarbaro J. A., Iseman M. D. Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Initial report of an eight-month, largely intermittent regimen in a population with a high prevalence of drug resistance. Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1301–1305. doi: 10.1164/ajrccm/142.6_Pt_1.1301. [DOI] [PubMed] [Google Scholar]
  158. McAdam J. M., Brickner P. W., Scharer L. L., Crocco J. A., Duff A. E. The spectrum of tuberculosis in a New York City men's shelter clinic (1982-1988) Chest. 1990 Apr;97(4):798–805. doi: 10.1378/chest.97.4.798. [DOI] [PubMed] [Google Scholar]
  159. McClatchy J. K., Kanes W., Davidson P. T., Moulding T. S. Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin. Tubercle. 1977 Mar;58(1):29–34. doi: 10.1016/s0041-3879(77)80007-x. [DOI] [PubMed] [Google Scholar]
  160. Menzies R., Vissandjee B., Rocher I., St Germain Y. The booster effect in two-step tuberculin testing among young adults in Montreal. Ann Intern Med. 1994 Feb 1;120(3):190–198. doi: 10.7326/0003-4819-120-3-199402010-00003. [DOI] [PubMed] [Google Scholar]
  161. Mitchell J. R., Zimmerman H. J., Ishak K. G., Thorgeirsson U. P., Timbrell J. A., Snodgrass W. R., Nelson S. D. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Ann Intern Med. 1976 Feb;84(2):181–192. doi: 10.7326/0003-4819-84-2-181. [DOI] [PubMed] [Google Scholar]
  162. Mitchison D. A., Nunn A. J. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis. 1986 Mar;133(3):423–430. doi: 10.1164/arrd.1986.133.3.423. [DOI] [PubMed] [Google Scholar]
  163. Mitchison D. A. Pyrazinamide in the chemoprophylaxis of tuberculosis. Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1467–1467. doi: 10.1164/ajrccm/142.6_Pt_1.1467. [DOI] [PubMed] [Google Scholar]
  164. Modilevsky T., Sattler F. R., Barnes P. F. Mycobacterial disease in patients with human immunodeficiency virus infection. Arch Intern Med. 1989 Oct;149(10):2201–2205. [PubMed] [Google Scholar]
  165. Monno L., Angarano G., Carbonara S., Coppola S., Costa D., Quarto M., Pastore G. Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients. Lancet. 1991 Apr 6;337(8745):852–852. doi: 10.1016/0140-6736(91)92559-k. [DOI] [PubMed] [Google Scholar]
  166. Moreno S., Baraia-Etxaburu J., Bouza E., Parras F., Pérez-Tascón M., Miralles P., Vicente T., Alberdi J. C., Cosín J., López-Gay D. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med. 1993 Aug 1;119(3):194–198. doi: 10.7326/0003-4819-119-3-199308010-00003. [DOI] [PubMed] [Google Scholar]
  167. Morris J. T., McAllister C. K. Homeless individuals and drug-resistant tuberculosis in south Texas. Chest. 1992 Sep;102(3):802–804. doi: 10.1378/chest.102.3.802. [DOI] [PubMed] [Google Scholar]
  168. Mosher C. B., Derebery V. J., Young B. J., Adams R. A. Unusually aggressive transmission of tuberculosis in a factory. J Occup Med. 1987 Jan;29(1):29–31. [PubMed] [Google Scholar]
  169. Mukadi Y., Perriëns J. H., St Louis M. E., Brown C., Prignot J., Willame J. C., Pouthier F., Kaboto M., Ryder R. W., Portaels F. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet. 1993 Jul 17;342(8864):143–146. doi: 10.1016/0140-6736(93)91346-n. [DOI] [PubMed] [Google Scholar]
  170. Nadler J. P., Berger J., Nord J. A., Cofsky R., Saxena M. Amoxicillin-clavulanic acid for treating drug-resistant Mycobacterium tuberculosis. Chest. 1991 Apr;99(4):1025–1026. doi: 10.1378/chest.99.4.1025. [DOI] [PubMed] [Google Scholar]
  171. Nardell E. A. Dodging droplet nuclei. Reducing the probability of nosocomial tuberculosis transmission in the AIDS era. Am Rev Respir Dis. 1990 Sep;142(3):501–503. doi: 10.1164/ajrccm/142.3.501. [DOI] [PubMed] [Google Scholar]
  172. Nardell E. A., Keegan J., Cheney S. A., Etkind S. C. Airborne infection. Theoretical limits of protection achievable by building ventilation. Am Rev Respir Dis. 1991 Aug;144(2):302–306. doi: 10.1164/ajrccm/144.2.302. [DOI] [PubMed] [Google Scholar]
  173. Nardell E., McInnis B., Thomas B., Weidhaas S. Exogenous reinfection with tuberculosis in a shelter for the homeless. N Engl J Med. 1986 Dec 18;315(25):1570–1575. doi: 10.1056/NEJM198612183152502. [DOI] [PubMed] [Google Scholar]
  174. Nichols L., Florentine B., Lewis W., Sattler F., Rarick M. U., Brynes R. K. Bone marrow examination for the diagnosis of mycobacterial and fungal infections in the acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1991 Nov;115(11):1125–1132. [PubMed] [Google Scholar]
  175. Nolan C. M., Elarth A. M., Barr H., Saeed A. M., Risser D. R. An outbreak of tuberculosis in a shelter for homeless men. A description of its evolution and control. Am Rev Respir Dis. 1991 Feb;143(2):257–261. doi: 10.1164/ajrccm/143.2.257. [DOI] [PubMed] [Google Scholar]
  176. Nolte F. S., Metchock B., McGowan J. E., Jr, Edwards A., Okwumabua O., Thurmond C., Mitchell P. S., Plikaytis B., Shinnick T. Direct detection of Mycobacterium tuberculosis in sputum by polymerase chain reaction and DNA hybridization. J Clin Microbiol. 1993 Jul;31(7):1777–1782. doi: 10.1128/jcm.31.7.1777-1782.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Noordhoek G. T., Kolk A. H., Bjune G., Catty D., Dale J. W., Fine P. E., Godfrey-Faussett P., Cho S. N., Shinnick T., Svenson S. B. Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol. 1994 Feb;32(2):277–284. doi: 10.1128/jcm.32.2.277-284.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Ormerod L. P. Reduced incidence of tuberculosis by prophylactic chemotherapy in subjects showing strong reactions to tuberculin testing. Arch Dis Child. 1987 Oct;62(10):1005–1008. doi: 10.1136/adc.62.10.1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Ormerod P., Skinner C. Reinfection tuberculosis: two cases in the family of a patient with drug-resistant disease. Thorax. 1980 Jan;35(1):56–59. doi: 10.1136/thx.35.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. PETERSDORF R. G., BEESON P. B. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore) 1961 Feb;40:1–30. doi: 10.1097/00005792-196102000-00001. [DOI] [PubMed] [Google Scholar]
  181. PUFFER R. R., ZEIDBERG L. D., DILLON A., GASS R. S., HUTCHESON R. H. Tuberculosis attack and death rates of household associates; the influence of age, sex, race, and relationship. Am Rev Tuberc. 1952 Feb;65(2):111–127. doi: 10.1164/art.1952.65.2.111. [DOI] [PubMed] [Google Scholar]
  182. Pablos-Mendez A., Raviglione M. C., Battan R. Drug-resistant tuberculosis in AIDS. Chest. 1990 Feb;97(2):511–512. doi: 10.1378/chest.97.2.511a. [DOI] [PubMed] [Google Scholar]
  183. Pao C. C., Yen T. S., You J. B., Maa J. S., Fiss E. H., Chang C. H. Detection and identification of Mycobacterium tuberculosis by DNA amplification. J Clin Microbiol. 1990 Sep;28(9):1877–1880. doi: 10.1128/jcm.28.9.1877-1880.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Pape J. W., Jean S. S., Ho J. L., Hafner A., Johnson W. D., Jr Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet. 1993 Jul 31;342(8866):268–272. doi: 10.1016/0140-6736(93)91817-6. [DOI] [PubMed] [Google Scholar]
  185. Pearson M. L., Jereb J. A., Frieden T. R., Crawford J. T., Davis B. J., Dooley S. W., Jarvis W. R. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers. Ann Intern Med. 1992 Aug 1;117(3):191–196. doi: 10.7326/0003-4819-117-3-191. [DOI] [PubMed] [Google Scholar]
  186. Pelletier A. R., DiFerdinando G. T., Jr, Greenberg A. J., Sosin D. M., Jones W. D., Jr, Bloch A. B., Woodley C. L. Tuberculosis in a correctional facility. Arch Intern Med. 1993 Dec 13;153(23):2692–2695. [PubMed] [Google Scholar]
  187. Peloquin C. A., Berning S. E. Comment: intravenous streptomycin. Ann Pharmacother. 1993 Dec;27(12):1546–1547. doi: 10.1177/106002809302701233. [DOI] [PubMed] [Google Scholar]
  188. Peloquin C. A., Berning S. E. Infection caused by Mycobacterium tuberculosis. Ann Pharmacother. 1994 Jan;28(1):72–84. doi: 10.1177/106002809402800115. [DOI] [PubMed] [Google Scholar]
  189. Peloquin C. A., MacPhee A. A., Berning S. E. Malabsorption of antimycobacterial medications. N Engl J Med. 1993 Oct 7;329(15):1122–1123. doi: 10.1056/NEJM199310073291513. [DOI] [PubMed] [Google Scholar]
  190. Peloquin C. A. Shortages of antimycobacterial drugs. N Engl J Med. 1992 Mar 5;326(10):714–714. doi: 10.1056/NEJM199203053261018. [DOI] [PubMed] [Google Scholar]
  191. Perriëns J. H., Colebunders R. L., Karahunga C., Willame J. C., Jeugmans J., Kaboto M., Mukadi Y., Pauwels P., Ryder R. W., Prignot J. Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire. Am Rev Respir Dis. 1991 Oct;144(4):750–755. doi: 10.1164/ajrccm/144.4.750. [DOI] [PubMed] [Google Scholar]
  192. Pierce J. R., Jr, Sims S. L., Holman G. H. Transmission of tuberculosis to hospital workers by a patient with AIDS. Chest. 1992 Feb;101(2):581–582. doi: 10.1378/chest.101.2.581. [DOI] [PubMed] [Google Scholar]
  193. Pierre C., Lecossier D., Boussougant Y., Bocart D., Joly V., Yeni P., Hance A. J. Use of a reamplification protocol improves sensitivity of detection of Mycobacterium tuberculosis in clinical samples by amplification of DNA. J Clin Microbiol. 1991 Apr;29(4):712–717. doi: 10.1128/jcm.29.4.712-717.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  194. Pitchenik A. E., Burr J., Cole C. H. Tuberculin testing for persons with positive serologic studies for HTLV-III. N Engl J Med. 1986 Feb 13;314(7):447–447. doi: 10.1056/NEJM198602133140713. [DOI] [PubMed] [Google Scholar]
  195. Pitchenik A. E., Burr J., Laufer M., Miller G., Cacciatore R., Bigler W. J., Witte J. J., Cleary T. Outbreaks of drug-resistant tuberculosis at AIDS centre. Lancet. 1990 Aug 18;336(8712):440–441. doi: 10.1016/0140-6736(90)91987-l. [DOI] [PubMed] [Google Scholar]
  196. Pitchenik A. E., Burr J., Suarez M., Fertel D., Gonzalez G., Moas C. Human T-cell lymphotropic virus-III (HTLV-III) seropositivity and related disease among 71 consecutive patients in whom tuberculosis was diagnosed. A prospective study. Am Rev Respir Dis. 1987 Apr;135(4):875–879. doi: 10.1164/arrd.1987.135.4.875. [DOI] [PubMed] [Google Scholar]
  197. Pitchenik A. E., Cole C., Russell B. W., Fischl M. A., Spira T. J., Snider D. E., Jr Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida. Ann Intern Med. 1984 Nov;101(5):641–645. doi: 10.7326/0003-4819-101-5-641. [DOI] [PubMed] [Google Scholar]
  198. Pitchenik A. E., Rubinson H. A. The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis. 1985 Mar;131(3):393–396. doi: 10.1164/arrd.1985.131.3.393. [DOI] [PubMed] [Google Scholar]
  199. Pitchenik A. E., Russell B. W., Cleary T., Pejovic I., Cole C., Snider D. E., Jr The prevalence of tuberculosis and drug resistance among Haitians. N Engl J Med. 1982 Jul 15;307(3):162–165. doi: 10.1056/NEJM198207153070306. [DOI] [PubMed] [Google Scholar]
  200. Pitchenik A. E. Tuberculosis control and the AIDS epidemic in developing countries. Ann Intern Med. 1990 Jul 15;113(2):89–91. doi: 10.7326/0003-4819-113-2-89. [DOI] [PubMed] [Google Scholar]
  201. Pitlik S. D., Fainstein V., Bodey G. P. Tuberculosis mimicking cancer--a reminder. Am J Med. 1984 May;76(5):822–825. doi: 10.1016/0002-9343(84)90993-8. [DOI] [PubMed] [Google Scholar]
  202. Plikaytis B. B., Plikaytis B. D., Yakrus M. A., Butler W. R., Woodley C. L., Silcox V. A., Shinnick T. M. Differentiation of slowly growing Mycobacterium species, including Mycobacterium tuberculosis, by gene amplification and restriction fragment length polymorphism analysis. J Clin Microbiol. 1992 Jul;30(7):1815–1822. doi: 10.1128/jcm.30.7.1815-1822.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. Plunkett R. E., Weber G. M., Siegal W., Donk R. R. Development of Tuberculosis in a Controlled Environment. Am J Public Health Nations Health. 1940 Mar;30(3):229–236. doi: 10.2105/ajph.30.3.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  204. Pomerantz M., Madsen L., Goble M., Iseman M. Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections. Ann Thorac Surg. 1991 Nov;52(5):1108–1112. doi: 10.1016/0003-4975(91)91289-8. [DOI] [PubMed] [Google Scholar]
  205. Prego V., Glatt A. E., Roy V., Thelmo W., Dincsoy H., Raufman J. P. Comparative yield of blood culture for fungi and mycobacteria, liver biopsy, and bone marrow biopsy in the diagnosis of fever of undetermined origin in human immunodeficiency virus-infected patients. Arch Intern Med. 1990 Feb;150(2):333–336. [PubMed] [Google Scholar]
  206. Rabalais G., Adams G., Stover B. PPD skin test conversion in health-care workers after exposure to Mycobacterium tuberculosis infection in infants. Lancet. 1991 Sep 28;338(8770):826–826. doi: 10.1016/0140-6736(91)90719-6. [DOI] [PubMed] [Google Scholar]
  207. Raleigh J. W., Wichelhausen R. H., Rado T. A., Bates J. H. Evidence for infection by two distinct strains of Mycobacterium tuberculosis in pulmonary tuberculosis: report of 9 cases. Am Rev Respir Dis. 1975 Oct;112(4):497–503. doi: 10.1164/arrd.1975.112.4.497. [DOI] [PubMed] [Google Scholar]
  208. Reichman L. B., Jordan T. J. Decision analysis comparing the tuberculin screening strategy with BCG vaccine. Am Rev Respir Dis. 1992 Mar;145(3):732–733. doi: 10.1164/ajrccm/145.3.732a. [DOI] [PubMed] [Google Scholar]
  209. Reichman L. B., O'Day R. Tuberculous infection in a large urban population. Am Rev Respir Dis. 1978 Apr;117(4):705–712. doi: 10.1164/arrd.1978.117.4.705. [DOI] [PubMed] [Google Scholar]
  210. Reichman L. B. The U-shaped curve of concern. Am Rev Respir Dis. 1991 Oct;144(4):741–742. doi: 10.1164/ajrccm/144.4.741. [DOI] [PubMed] [Google Scholar]
  211. Reves R., Blakey D., Snider D. E., Jr, Farer L. S. Transmission of multiple drug-resistant tuberculosis: report of a school and community outbreak. Am J Epidemiol. 1981 Apr;113(4):423–435. doi: 10.1093/oxfordjournals.aje.a113110. [DOI] [PubMed] [Google Scholar]
  212. Rieder H. L., Cauthen G. M., Kelly G. D., Bloch A. B., Snider D. E., Jr Tuberculosis in the United States. JAMA. 1989 Jul 21;262(3):385–389. [PubMed] [Google Scholar]
  213. Riley L. W., Arathoon E., Loverde V. D. The epidemiologic patterns of drug-resistant Mycobacterium tuberculosis infections: a community-based study. Am Rev Respir Dis. 1989 May;139(5):1282–1285. doi: 10.1164/ajrccm/139.5.1282. [DOI] [PubMed] [Google Scholar]
  214. Riley R. L., Nardell E. A. Clearing the air. The theory and application of ultraviolet air disinfection. Am Rev Respir Dis. 1989 May;139(5):1286–1294. doi: 10.1164/ajrccm/139.5.1286. [DOI] [PubMed] [Google Scholar]
  215. Roberts G. D., Goodman N. L., Heifets L., Larsh H. W., Lindner T. H., McClatchy J. K., McGinnis M. R., Siddiqi S. H., Wright P. Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol. 1983 Sep;18(3):689–696. doi: 10.1128/jcm.18.3.689-696.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  216. Rodier G., Gravier P., Sèvre J. P., Binson G., Omar C. S. Multidrug-resistant tuberculosis in the Horn of Africa. J Infect Dis. 1993 Aug;168(2):523–524. doi: 10.1093/infdis/168.2.523. [DOI] [PubMed] [Google Scholar]
  217. Rosenberg T., Manfreda J., Hershfield E. S. Two-step tuberculin testing in staff and residents of a nursing home. Am Rev Respir Dis. 1993 Dec;148(6 Pt 1):1537–1540. doi: 10.1164/ajrccm/148.6_Pt_1.1537. [DOI] [PubMed] [Google Scholar]
  218. SHAW J. B., WYNN-WILLIAMS N. Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc. 1954 May;69(5):724–732. doi: 10.1164/art.1954.69.5.724. [DOI] [PubMed] [Google Scholar]
  219. Sacks J. J., Brenner E. R., Breeden D. C., Anders H. M., Parker R. L. Epidemiology of a tuberculosis outbreak in a South Carolina junior high school. Am J Public Health. 1985 Apr;75(4):361–365. doi: 10.2105/ajph.75.4.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  221. Saltzman B. R., Motyl M. R., Friedland G. H., McKitrick J. C., Klein R. S. Mycobacterium tuberculosis bacteremia in the acquired immunodeficiency syndrome. JAMA. 1986 Jul 18;256(3):390–391. [PubMed] [Google Scholar]
  222. Sbarbaro J. To treat or not to treat, that was the question. Am Rev Respir Dis. 1989 Apr;139(4):865–866. doi: 10.1164/ajrccm/139.4.865. [DOI] [PubMed] [Google Scholar]
  223. Scalcini M., Carré G., Jean-Baptiste M., Hershfield E., Parker S., Wolfe J., Nelz K., Long R. Antituberculous drug resistance in central Haiti. Am Rev Respir Dis. 1990 Sep;142(3):508–511. doi: 10.1164/ajrccm/142.3.508. [DOI] [PubMed] [Google Scholar]
  224. Schieffelbein C. W., Jr, Snider D. E., Jr Tuberculosis control among homeless populations. Arch Intern Med. 1988 Aug;148(8):1843–1846. [PubMed] [Google Scholar]
  225. Schluger N. W., Rom W. N. Current approaches to the diagnosis of active pulmonary tuberculosis. Am J Respir Crit Care Med. 1994 Jan;149(1):264–267. doi: 10.1164/ajrccm.149.1.8111591. [DOI] [PubMed] [Google Scholar]
  226. Selwyn P. A., Hartel D., Lewis V. A., Schoenbaum E. E., Vermund S. H., Klein R. S., Walker A. T., Friedland G. H. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989 Mar 2;320(9):545–550. doi: 10.1056/NEJM198903023200901. [DOI] [PubMed] [Google Scholar]
  227. Selwyn P. A., Sckell B. M., Alcabes P., Friedland G. H., Klein R. S., Schoenbaum E. E. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA. 1992 Jul 22;268(4):504–509. [PubMed] [Google Scholar]
  228. Sepkowitz K. A., Telzak E. E., Carrow M., Armstrong D. Fever among outpatients with advanced human immunodeficiency virus infection. Arch Intern Med. 1993 Aug 23;153(16):1909–1912. [PubMed] [Google Scholar]
  229. Sepkowitz K. A., Telzak E. E., Recalde S., Armstrong D. Trends in the susceptibility of tuberculosis in New York City, 1987-1991. New York City Area Tuberculosis Working Group. Clin Infect Dis. 1994 May;18(5):755–759. doi: 10.1093/clinids/18.5.755. [DOI] [PubMed] [Google Scholar]
  230. Sepkowitz K. A. Tuberculosis and the health care worker: a historical perspective. Ann Intern Med. 1994 Jan 1;120(1):71–79. doi: 10.7326/0003-4819-120-1-199401010-00012. [DOI] [PubMed] [Google Scholar]
  231. Shafer R. W., Chirgwin K. D., Glatt A. E., Dahdouh M. A., Landesman S. H., Suster B. HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS. AIDS. 1991 Apr;5(4):399–405. doi: 10.1097/00002030-199104000-00007. [DOI] [PubMed] [Google Scholar]
  232. Shafer R. W., Kim D. S., Weiss J. P., Quale J. M. Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine (Baltimore) 1991 Nov;70(6):384–397. doi: 10.1097/00005792-199111000-00004. [DOI] [PubMed] [Google Scholar]
  233. Shawar R. M., el-Zaatari F. A., Nataraj A., Clarridge J. E. Detection of Mycobacterium tuberculosis in clinical samples by two-step polymerase chain reaction and nonisotopic hybridization methods. J Clin Microbiol. 1993 Jan;31(1):61–65. doi: 10.1128/jcm.31.1.61-65.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  234. Shireman P. K. Endometrial tuberculosis acquired by a health care worker in a clinical laboratory. Arch Pathol Lab Med. 1992 May;116(5):521–523. [PubMed] [Google Scholar]
  235. Siddiqi S. H., Hwangbo C. C., Silcox V., Good R. C., Snider D. E., Jr, Middlebrook G. Rapid radiometric methods to detect and differentiate Mycobacterium tuberculosis/M. bovis from other mycobacterial species. Am Rev Respir Dis. 1984 Oct;130(4):634–640. doi: 10.1164/arrd.1984.130.4.634. [DOI] [PubMed] [Google Scholar]
  236. Slutkin G., Schecter G. F., Hopewell P. C. The results of 9-month isoniazid-rifampin therapy for pulmonary tuberculosis under program conditions in San Francisco. Am Rev Respir Dis. 1988 Dec;138(6):1622–1624. doi: 10.1164/ajrccm/138.6.1622. [DOI] [PubMed] [Google Scholar]
  237. Slutsker L., Castro K. G., Ward J. W., Dooley S. W., Jr Epidemiology of extrapulmonary tuberculosis among persons with AIDS in the United States. Clin Infect Dis. 1993 Apr;16(4):513–518. doi: 10.1093/clind/16.4.513. [DOI] [PubMed] [Google Scholar]
  238. Small P. M., Schecter G. F., Goodman P. C., Sande M. A., Chaisson R. E., Hopewell P. C. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med. 1991 Jan 31;324(5):289–294. doi: 10.1056/NEJM199101313240503. [DOI] [PubMed] [Google Scholar]
  239. Small P. M., Shafer R. W., Hopewell P. C., Singh S. P., Murphy M. J., Desmond E., Sierra M. F., Schoolnik G. K. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med. 1993 Apr 22;328(16):1137–1144. doi: 10.1056/NEJM199304223281601. [DOI] [PubMed] [Google Scholar]
  240. Smith M. H. Tuberculosis in children and adolescents. Clin Chest Med. 1989 Sep;10(3):381–395. [PubMed] [Google Scholar]
  241. Snider D. E., Graczyk J., Bek E., Rogowski J. Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin. Am Rev Respir Dis. 1984 Dec;130(6):1091–1094. doi: 10.1164/arrd.1984.130.6.1091. [DOI] [PubMed] [Google Scholar]
  242. Snider D. E., Jr, Cauthen G. M., Farer L. S., Kelly G. D., Kilburn J. O., Good R. C., Dooley S. W. Drug-resistant tuberculosis. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):732–732. doi: 10.1164/ajrccm/144.3_Pt_1.732. [DOI] [PubMed] [Google Scholar]
  243. Snider D. E., Jr, Hutton M. D. Tuberculosis in correctional institutions. JAMA. 1989 Jan 20;261(3):436–437. [PubMed] [Google Scholar]
  244. Snider D. E., Jr, Long M. W., Cross F. S., Farer L. S. Six-months isoniazid-rifampin therapy for pulmonary tuberculosis. Report of a United States Public Health Service Cooperative Trial. Am Rev Respir Dis. 1984 Apr;129(4):573–579. [PubMed] [Google Scholar]
  245. Soeiro R. A tale of two mutants. N Engl J Med. 1993 Apr 22;328(16):1192–1193. doi: 10.1056/NEJM199304223281610. [DOI] [PubMed] [Google Scholar]
  246. Stack R. J., Bickley L. K., Coppel I. G. Miliary tuberculosis presenting as skin lesions in a patient with acquired immunodeficiency syndrome. J Am Acad Dermatol. 1990 Nov;23(5 Pt 2):1031–1035. doi: 10.1016/0190-9622(90)70331-b. [DOI] [PubMed] [Google Scholar]
  247. Stead W. W. Annual tuberculosis screening of hospital employees--an idea whose time has not passed. Am Rev Respir Dis. 1987 Oct;136(4):803–804. doi: 10.1164/ajrccm/136.4.803. [DOI] [PubMed] [Google Scholar]
  248. Stead W. W. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am Rev Respir Dis. 1967 May;95(5):729–745. doi: 10.1164/arrd.1967.95.5.729. [DOI] [PubMed] [Google Scholar]
  249. Stead W. W. Pathogenesis of the sporadic case of tuberculosis. N Engl J Med. 1967 Nov 9;277(19):1008–1012. doi: 10.1056/NEJM196711092771906. [DOI] [PubMed] [Google Scholar]
  250. Stead W. W., To T., Harrison R. W., Abraham J. H., 3rd Benefit-risk considerations in preventive treatment for tuberculosis in elderly persons. Ann Intern Med. 1987 Dec;107(6):843–845. doi: 10.7326/0003-4819-107-6-843. [DOI] [PubMed] [Google Scholar]
  251. Stead W. W. Tuberculosis among elderly persons: an outbreak in a nursing home. Ann Intern Med. 1981 May;94(5):606–610. doi: 10.7326/0003-4819-94-5-606. [DOI] [PubMed] [Google Scholar]
  252. Stead W. W. Undetected tuberculosis in prison. Source of infection for community at large. JAMA. 1978 Dec 1;240(23):2544–2547. doi: 10.1001/jama.240.23.2544. [DOI] [PubMed] [Google Scholar]
  253. Steele M. A., Burk R. F., DesPrez R. M. Toxic hepatitis with isoniazid and rifampin. A meta-analysis. Chest. 1991 Feb;99(2):465–471. doi: 10.1378/chest.99.2.465. [DOI] [PubMed] [Google Scholar]
  254. Steiner P., Rao M., Victoria M. S., Hunt J., Steiner M. A continuing study of primary drug-resistant tuberculosis among children observed at the Kings County Hospital Medical Center between the years 1961 and 1980. Am Rev Respir Dis. 1983 Sep;128(3):425–428. doi: 10.1164/arrd.1983.128.3.425. [DOI] [PubMed] [Google Scholar]
  255. Stoeckle M. Y., Guan L., Riegler N., Weitzman I., Kreiswirth B., Kornblum J., Laraque F., Riley L. W. Catalase-peroxidase gene sequences in isoniazid-sensitive and -resistant strains of Mycobacterium tuberculosis from New York City. J Infect Dis. 1993 Oct;168(4):1063–1065. doi: 10.1093/infdis/168.4.1063. [DOI] [PubMed] [Google Scholar]
  256. Sumartojo E. When tuberculosis treatment fails. A social behavioral account of patient adherence. Am Rev Respir Dis. 1993 May;147(5):1311–1320. doi: 10.1164/ajrccm/147.5.1311. [DOI] [PubMed] [Google Scholar]
  257. Sunderam G., Mangura B. T., Lombardo J. M., Reichman L. B. Failure of "optimal" four-drug short-course tuberculosis chemotherapy in a compliant patient with human immunodeficiency virus. Am Rev Respir Dis. 1987 Dec;136(6):1475–1478. doi: 10.1164/ajrccm/136.6.1475. [DOI] [PubMed] [Google Scholar]
  258. Sunderam G., McDonald R. J., Maniatis T., Oleske J., Kapila R., Reichman L. B. Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). JAMA. 1986 Jul 18;256(3):362–366. [PubMed] [Google Scholar]
  259. Takewaki S., Okuzumi K., Ishiko H., Nakahara K., Ohkubo A., Nagai R. Genus-specific polymerase chain reaction for the mycobacterial dnaJ gene and species-specific oligonucleotide probes. J Clin Microbiol. 1993 Feb;31(2):446–450. doi: 10.1128/jcm.31.2.446-450.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  260. Telenti A., Marchesi F., Balz M., Bally F., Böttger E. C., Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol. 1993 Feb;31(2):175–178. doi: 10.1128/jcm.31.2.175-178.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  261. Tenover F. C., Crawford J. T., Huebner R. E., Geiter L. J., Horsburgh C. R., Jr, Good R. C. The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol. 1993 Apr;31(4):767–770. doi: 10.1128/jcm.31.4.767-770.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  262. Thierry D., Brisson-Noël A., Vincent-Lévy-Frébault V., Nguyen S., Guesdon J. L., Gicquel B. Characterization of a Mycobacterium tuberculosis insertion sequence, IS6110, and its application in diagnosis. J Clin Microbiol. 1990 Dec;28(12):2668–2673. doi: 10.1128/jcm.28.12.2668-2673.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  263. Toossi Z., Sierra-Madero J. G., Blinkhorn R. A., Mettler M. A., Rich E. A. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J Exp Med. 1993 May 1;177(5):1511–1516. doi: 10.1084/jem.177.5.1511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  264. Torres R. A., Mani S., Altholz J., Brickner P. W. Human immunodeficiency virus infection among homeless men in a New York City shelter. Association with Mycobacterium tuberculosis infection. Arch Intern Med. 1990 Oct;150(10):2030–2036. [PubMed] [Google Scholar]
  265. Twinam C. W., Pope A. S. Pulmonary Tuberculosis Resulting from Extra-Familial Contacts. Am J Public Health Nations Health. 1942 Nov;32(11):1215–1218. doi: 10.2105/ajph.32.11.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  266. Vennema A. Contact investigation and isoniazid chemoprophylaxis in New York City, 1979-1987. N Y State J Med. 1992 May;92(5):185–188. [PubMed] [Google Scholar]
  267. Wallis R. S., Vjecha M., Amir-Tahmasseb M., Okwera A., Byekwaso F., Nyole S., Kabengera S., Mugerwa R. D., Ellner J. J. Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis. J Infect Dis. 1993 Jan;167(1):43–48. doi: 10.1093/infdis/167.1.43. [DOI] [PubMed] [Google Scholar]
  268. Weis S. E., Slocum P. C., Blais F. X., King B., Nunn M., Matney G. B., Gomez E., Foresman B. H. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 1994 Apr 28;330(17):1179–1184. doi: 10.1056/NEJM199404283301702. [DOI] [PubMed] [Google Scholar]
  269. Welsh C. H. Drug-resistant tuberculosis after gastrectomy. Double jeopardy? Chest. 1991 Jan;99(1):245–247. doi: 10.1378/chest.99.1.245. [DOI] [PubMed] [Google Scholar]
  270. Werhane M. J., Snukst-Torbeck G., Schraufnagel D. E. The tuberculosis clinic. Chest. 1989 Oct;96(4):815–818. doi: 10.1378/chest.96.4.815. [DOI] [PubMed] [Google Scholar]
  271. Wilson S. M., McNerney R., Nye P. M., Godfrey-Faussett P. D., Stoker N. G., Voller A. Progress toward a simplified polymerase chain reaction and its application to diagnosis of tuberculosis. J Clin Microbiol. 1993 Apr;31(4):776–782. doi: 10.1128/jcm.31.4.776-782.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  272. Witebsky F. G., Keiser J. F., Conville P. S., Bryan R., Park C. H., Walker R., Siddiqi S. H. Comparison of BACTEC 13A medium and Du Pont isolator for detection of mycobacteremia. J Clin Microbiol. 1988 Aug;26(8):1501–1505. doi: 10.1128/jcm.26.8.1501-1505.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  273. Yew W. W., Kwan S. Y., Ma W. K., Khin M. A., Chau P. Y. In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosis. J Antimicrob Chemother. 1990 Aug;26(2):227–236. doi: 10.1093/jac/26.2.227. [DOI] [PubMed] [Google Scholar]
  274. Yew W. W., Wong C. F., Wong P. C., Lee J., Chau C. H. Adverse neurological reactions in patients with multidrug-resistant pulmonary tuberculosis after coadministration of cycloserine and ofloxacin. Clin Infect Dis. 1993 Aug;17(2):288–289. doi: 10.1093/clinids/17.2.288. [DOI] [PubMed] [Google Scholar]
  275. ZEIDBERG L. D., GASS R. S., DILLON A., HUTCHESON R. H. The Williamson County Tuberculosis Study. A twenty-four-year epidemiologic study. Am Rev Respir Dis. 1963 Mar;87(3):1–88. [PubMed] [Google Scholar]
  276. Zhang Y., Heym B., Allen B., Young D., Cole S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature. 1992 Aug 13;358(6387):591–593. doi: 10.1038/358591a0. [DOI] [PubMed] [Google Scholar]
  277. Zierski M., Bek E., Long M. W., Snider D. E., Jr Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment. Am Rev Respir Dis. 1980 Dec;122(6):879–889. doi: 10.1164/arrd.1980.122.6.879. [DOI] [PubMed] [Google Scholar]
  278. van Embden J. D., Cave M. D., Crawford J. T., Dale J. W., Eisenach K. D., Gicquel B., Hermans P., Martin C., McAdam R., Shinnick T. M. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993 Feb;31(2):406–409. doi: 10.1128/jcm.31.2.406-409.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES